Esteve Healthcare SL - Company Profile
Powered by 
All the sales intelligence you need on Esteve Healthcare SL in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Esteve Healthcare SL fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Esteve Healthcare SL.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Esteve Healthcare SL (Esteve) researches, develops, and markets prescription and generic pharmaceuticals. The company's product portfolio includes prescription drugs, over-the-counter (OTC) pharmaceuticals, and generic drugs. It offers drugs for the central nervous system, infection, respiratory, cardiovascular, cancer, primary care and other therapeutic areas. Esteve also provides customized contract manufacturing services of active pharmaceutical ingredients (APIs) and advanced intermediates for the global pharmaceutical industry. The company markets its products to pharmaceutical companies, healthcare facilities and other customers through licensing agreements and distributors. It operates subsidiaries and production centers in Europe, the Americas, Africa, Oceania and Asia. Esteve is headquartered in Barcelona, Spain.
Headquarters
Spain
Address
Passeig de la Zona Franca, 109, 4th Floor, Passeig de la Zona Franca, Barcelona, Barcelona , 08038
Website
www.esteve.com/es
Telephone
34 93 4466000
No of Employees
2,223
Industry
Pharmaceuticals and Healthcare
Revenue (2025)
$934.2M
Esteve Healthcare SL premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Prescription | Contract Manufacturing Services | Retinest |
| Vision Care | Velyntra | |
| Integral Care | Seglentis | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Acquisitions/Mergers/Takeovers | In July, the company acquired Regis Technologies, a contract development and manufacturing company. |
| 2025 | Contracts/Agreements | In June, the company signed an agreement to acquire the rights of Caprelsa (vandetanib) from Sanofi for over 50 countries, expanding treatment options for medullary thyroid cancer. |
| 2024 | Acquisitions/Mergers/Takeovers | In July, the company acquired HRA Pharma Rare Diseases business from Perrigo Company plc for EUR275 million. |
Competitor Comparison
| Key Parameters | Esteve Healthcare SL | Almirall SA | J Uriach Y Compania SA | Covex SA | Lacer SAU |
|---|---|---|---|---|---|
| Headquarters | Spain | Spain | Spain | Spain | Spain |
| City | Barcelona | Barcelona | Barcelona | Madrid | Barcelona |
| State/Province | Barcelona | Barcelona | Barcelona | Madrid | Barcelona |
| No. of Employees | 2,223 | 2,108 | 1,300 | - | 20 |
| Entity Type | Private | Public | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Albert Esteve | Chairman | Executive Board | 2018 | 67 |
| Staffan Schuberg | Chief Executive Officer; Director | Executive Board | 2018 | 57 |
| Daniel Girona | Chief Legal Officer; Director | Executive Board | 2024 | 54 |
| Roser Gomila | Chief Financial Officer | Senior Management | 2023 | 56 |
| Maria Angels Valls | Chief Communications Officer; Chief Public Affairs Officer | Senior Management | 2019 | 60 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer